Ulcerative Colitis Treatments

Find Ulcerative Colitis Treatments

Generic Name

Mesalamine

Brand Names

Pentasa, Apriso, Canasa, Lialda, Rowasa, sfRowasa Sulfite-Free

FDA approval date: May 10, 1993

Classification: Aminosalicylate

Form: Suppository, Tablet, Enema, Kit, Suspension, Capsule

What is Pentasa (Mesalamine)?

Mesalamine rectal suspension enema is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis in adults. Mesalamine rectal suspension enema is an aminosalicylate indicated for treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis in adults.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Clinical Study Evaluating Safety and Efficacy of Pentoxifylline in Patients With Ulcerative Colitis

Enrollment Status: Recruiting

Publish Date: April 15, 2026

Intervention Type: Drug

Study Phase: Phase 2

Summary: Ulcerative colitis (UC) is a persistent, idiopathic form of inflammatory bowel disease (IBD) marked by uninterrupted inflammation of the colon's mucosal lining, usually starting at the rectum and progressing proximally in a continuous manner. It manifests clinically with recurrent episodes of abdominal pain, bloody diarrhea, urgency, tenesmus, and weight loss. The precise cause of UC is still unkn...

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

Enrollment Status: Recruiting

Publish Date: March 13, 2026

Intervention Type: Drug

Study Phase: Phase 2/Phase 3

Summary: The inflammatory bowel diseases (IBD) are described as complex, recurrent inflammatory conditions which are manifested as Crohn's disease (CD) and ulcerative colitis (UC). The common symptoms of IBD include debilitating/severe diarrhea, abdominal pain, weight loss, and chronic fatigue; events that may culminate in life-threatening complications. The pathogenesis of IBD has been characterized as co...

Clinical Study to Evaluate the Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine

Enrollment Status: Recruiting

Publish Date: February 06, 2026

Intervention Type: Drug

Study Phase: Not Applicable

Summary: To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative colitis treated with mesalamine

View All Clinical Trials